1. Cerletti U. Un nuevo metode di shockterapie “L’elettro-shock”. Boll Accad Med Roma 1938;64:136-138.
2. McCall WV. Electroconvulsive therapy in the era of modern psychopharmacology. Int J Neuropsychopharmacol 2001;4:315-324.
3. Lesage A, Lemasson M, Medina K, Tsopmo J, Sebti N, Potvin S, et al. The prevalence of electroconvulsive therapy use since 1973: a meta-analysis. J ECT 2016;32:236-242.
4. Jolivet A, Grözinger M. Electroconvulsive therapy in Germany: development over 8 years with a background of 4 decades. J ECT 2021;37:30-35.
5. Sanghani SN, Petrides G, Kellner CH. Electroconvulsive therapy (ECT) in schizophrenia: a review of recent literature. Curr Opin Psychiatry 2018;31:213-222.
9. Xiang YT, Ungvari GS, Correll CU, Chiu HF, Lai KY, Wang CY, et al. Use of electroconvulsive therapy for Asian patients with schizophrenia (2001-2009): trends and correlates. Psychiatry Clin Neurosci 2015;69:489-496.
10. Abbiati V, Broglia D, De Micheli A, Gaio F, Maccagnoni S, Pezzini F, et al. [La terapia elettroconvulsiva: revisione critica del suo utilizzo in Italia]. Bollettino della Società Medico Chirurgica di Pavia 2010;123:725-732. Italian.
11. Nordanskog P, Hultén M, Landén M, Lundberg J, von Knorring L, Nordenskjöld A. Electroconvulsive therapy in Sweden 2013: data from the national quality register for ECT. J ECT 2015;31:263-267.
14. World Health Organization. ICD-10: international statistical classification of diseases and related health problems: tenth revision. Volume 3: alphabetical index (2nd ed). Geneva: World Health Organization; 2004.
16. Ga H, Won CW. Perspective on long term care hospitals in Korea. J Am Med Dir Assoc 2013;14:770-772.
17. Suh GH. Mental healthcare in South Korea. Int Psychiatry 2005;2:10-12.
22. Subramanian S, Fahed M, Dix E, Wilkins KM. Emergent and nonemergent agitation in the older adult: evaluation and management. Curr Geri Rep 2021;10:73-81.
25. Balasubramanian I, Abhijita B, Menon V. Electroconvulsive therapy as maintenance treatment in psychiatric disorders. Curr Behav Neurosci Rep 2024;11:1-13.
26. Birmaher B, Brent D, Bernet W, Bukstein O, Walter H, Benson RS, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007;46:1503-1526.
27. Trivedi C, Motiwala F, Mainali P, Mansuri Z, Jain S. Trends for electroconvulsive therapy utilization in children and adolescents in the United States from 2002 to 2017: a nationwide inpatient sample analysis. J ECT 2021;37:100-106.
28. Puffer CC, Wall CA, Huxsahl JE, Frye MA. A 20 year practice review of electroconvulsive therapy for adolescents. J Child Adolesc Psychopharmacol 2016;26:632-636.
29. Ghaziuddin N, Kaza M, Ghazi N, King C, Walter G, Rey JM. Electroconvulsive therapy for minors: experiences and attitudes of child psychiatrists and psychologists. J ECT 2001;17:109-117.
30. Longenecker LM. Suicide, precarity, and Korean media: a sociocultural analysis of the adolescent suicide epidemic in South Korea [dissertation]. Austin, University of Texas at Austin. 2019.
32. Kuehner C. Why is depression more common among women than among men? Lancet Psychiatry 2017;4:146-158.
35. Nivoli AM, Pacchiarotti I, Rosa AR, Popovic D, Murru A, Valenti M, et al. Gender differences in a cohort study of 604 bipolar patients: the role of predominant polarity. J Affect Disord 2011;133:443-449.
36. Blanken MAJT, Oudega ML, Hoogendoorn AW, Sonnenberg CS, Rhebergen D, Klumpers UMH, et al. Sex-specifics of ECT outcome. J Affect Disord 2023;326:243-248.
37. Chanpattana W, Kramer BA, Kunigiri G, Gangadhar BN, Kitphati R, Andrade C. A survey of the practice of electroconvulsive therapy in Asia. J ECT 2010;26:5-10.
41. Tairova Z. Model of development of “smart industry” in the Republic of Korea in the conditions of innovative economy. Mod Sci Res 2024;3:1-6.
43. Sidhom E, Omar MH. The nomenclature of electroconvulsive therapy. J ECT 2021;37:128-132.
44. Xiang YT, Ungvari GS, Correll CU, Chiu HF, Shinfuku N. Trends in the access to and the use of antipsychotic medications and psychotropic co-treatments in Asian patients with schizophrenia. Epidemiol Psychiatr Sci 2016;25:9-17.
45. Boylan LS, Haskett RF, Mulsant BH, Greenberg RM, Prudic J, Spicknall K, et al. Determinants of seizure threshold in ECT: benzodiazepine use, anesthetic dosage, and other factors. J ECT 2000;16:3-18.
46. Salik I, Marwaha R. Electroconvulsive therapy. Treasure Island: StatPearls Publishing; 2022.
49. Munk-Olsen T, Laursen TM, Videbech P, Mortensen PB, Rosenberg R. All-cause mortality among recipients of electroconvulsive therapy: register-based cohort study. Br J Psychiatry 2007;190:435-439.
52. Demchenko I, Blumberger DM, Flint AJ, Anderson M, Daskalakis ZJ, Foley K, et al. Electroconvulsive therapy in Canada during the first wave of COVID-19: results of the “what happened” national survey. J ECT 2022;38:52-59.